Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministry of Health, Burkina Faso | OTHER_GOV |
| Terre des hommes, Burkina Faso & Switzerland | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The Integrated Management of Childhood Illness (IMCI) guideline has been implemented in Burkina Faso and is used across primary health facilities to assess children under the age of 5 years. A part from a rapid diagnostic test (RDT) for malaria, no other point of care in vitro diagnostic tests are widely used to improve disease diagnosis and inform treatment decisions. Dengue fever has been reported in Burkina Faso since 1925 and the recent epidemics in 2016 and 2017 have prompted the government to validate and deploy a clinical management algorithm for Dengue and a case reporting process to support surveillance for a targeted response.
The organisation Terre des hommes has digitalised IMCI and implemented the module through its Integrated electronic Diagnosis Approach (IeDA) programme across primary health care centers (PHCs) in the country with proven impact on clinical care and proven reduction in antibiotic prescriptions. Many recognize the need to update the IMCI guideline with current evidence. However this is challenging and may require large clinical trials. The advantage of electronic clinical decision support systems is plural: they improve quality of care through increased adherence and feedback information to the system; they strengthen surveillance systems by connecting relevant patient related data and provide geo-tagged coordinates for targeted responses; and they can become evidence-adaptive.
An electronic module of the Burkina Faso Dengue clinical management guideline accompanied with dengue rapid diagnostic tests has the potential to improve the diagnosis of non-malaria fevers in particular during "dengue seasons" and improve the efficiency of surveillance for this disease.
In this study, the investigators aim to assess the usability and the performance of the dengue module for patient management in primary health care facilities.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dengue module and rapid diagnostic tests | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dengue module and rapid diagnostic tests | Other | Digital platform providing clinical decision support for Dengue, Dengue rapid diagnostic tests and training will be deployed at study sites for Dengue screening, diagnosis, case management as well as reporting to surveillance system following local guidelines |
| Measure | Description | Time Frame |
|---|---|---|
| Point estimates of the percentage of dengue consultations performed using the dengue module, with 95% confidence intervals | This outcome will be evaluated by reporting the ratio of dengue consultations performed using the dengue module over the total number of consultations, together with a 95% confidence interval based on Wilson's score method. | 4 months |
| Evaluation of the adherence to the different steps of the module | This outcome will be evaluated by the percentage ratio of dengue module steps adhered by patients over the total number of patients at each step. | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Estimate of the operational characteristic, Efficacy, of the dengue module: percentage of forms emitted from the module received in the surveillance system | 4 months | |
| Estimate of the operational characteristic, Timeliness, of the dengue module: percentage of forms that are received by the surveillance system on time, as defined by the national surveillance system. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Brice W Bicaba, MD | Contact | +22670264393 | bicaba_brico@yahoo.fr | |
| Maimouna Sow, MD | Contact | +22670264393 | beldoso@yahoo.fr |
| Name | Affiliation | Role |
|---|---|---|
| Brice W Bicaba, MD | Ministry of Health, Burkina Faso | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre de Santé et de Promotion Sociale (Sandogo) | Recruiting | Ouagadougou | District Boulmiougou | Burkina Faso |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003715 | Dengue |
| ID | Term |
|---|---|
| D000096724 | Mosquito-Borne Diseases |
| D000079426 | Vector Borne Diseases |
| D007239 | Infections |
| D001102 | Arbovirus Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D000092025 | Rapid Diagnostic Tests |
| ID | Term |
|---|---|
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 4 months |
| Estimate of operational characteristic, Completeness, of the dengue module: percentage of fields that are completed. | 4 months |
| Positive predictive value of dengue rapid diagnostic test | Polymerase chain reaction results will be used as the reference test. | 4 months |
| Centre de Santé et de Promotion Sociale (Secteur 16) | Recruiting | Ouagadougou | District Boulmiougou | Burkina Faso |
|
| D014777 |
| Virus Diseases |
| D018177 | Flavivirus Infections |
| D018178 | Flaviviridae Infections |
| D012327 | RNA Virus Infections |
| D006482 | Hemorrhagic Fevers, Viral |
| D000067716 | Point-of-Care Testing |
| D019095 | Point-of-Care Systems |
| D010346 | Patient Care Management |
| D006298 | Health Services Administration |